Contraceptives Market Share Growth Size Trends Report with Allergan Biologics Ltd., Bayer, CooperSurgical, Church & Dwight Co., Inc., Merck, Pfizer, RECKITT BENCKISER GROUP PLC

Contraceptives Market size was valued over USD 21.1 billion in 2016 and is expected to witness more than 6.8% CAGR from 2017 to 2024 according to a new research report by Global Market Insights
Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population will create huge demand for contraceptives during the forecast period. Various programs aiming to meet the need for modern contraception and provide reproductive and sexual health services should involve a good participation of women, adolescents, and young people, at all stages of planning, implementation, and evaluation.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/430

An increasing number of women are postponing motherhood as they prioritize their careers. Moreover, balancing concerns of the cost for raising a child, ambiguity over job safety and unstable relationships are increasingly causing women to postpone pregnancy.

In 2015, globally 64% of in-union or married women of fertile age were using some mode of contraception. Nevertheless, contraceptive use was much lesser in the under developed countries and was particularly low in Africa where only 33% of women are projected to use the products so far. High unmet needs in developing nation will fuel the market size. Demand for contraceptives would rise owing to rising numbers of new HIV infections in many countries over the coming years.

Growing geriatric population across European nations coupled with rising incidence of lifestyle disorders will induce infertility eventually reducing the demand for contraception products. Moreover, concerns regarding the side effects of products can negatively impact the product demand in future.

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/contraceptives-market-report

Contraceptive devices hold major market share owing to more effectiveness and long-term effect. The segment is rapidly adopted worldwide and will continue to grow during the forecast period. Some of the commonly used devices are condoms, diaphragms, sponges, rings, sub-dermal implants and intrauterine devices (IUD). Condoms are most popular choice worldwide and hold largest market share. Copper IUD is mainly preferred by the women who do not wish to use hormonal form to avoid possible side effects.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
 Allergan Biologics Ltd
 Bayer
 CooperSurgical
 Church & Dwight Co., Inc.
 Merck
 Pfizer
 RECKITT BENCKISER GROUP PLC

Contraceptive drugs will witness robust growth owing to rising prevalence of STDs and lack of family planning. Favourable regulatory scenario and awareness programs will strengthen segment growth. Various forms of drugs include hormonal oral pills, topical and injectable contraceptives. Oral pills market held major revenue share of contraceptives market due to high consumption rate. Daily consumption of these pills facilitates acne reduction, reduces cramping during periods, and minimizes the risk of developing cervical & endometrial cancers powering the overall market growth. However, irregular bleeding, increased risk of developing sexually transmitted infections (STIs), nausea, and migraine are some of the disadvantages related with oral pills eventually hampering segment growth.

U.S. held major revenue share of contraceptives market in future owing to presence of sophisticated healthcare facilities, growing demand for contraceptives for preventing unwanted pregnancies, and favourable regulatory scenario. The use of contraceptives in UK is noticeably high compared to the other countries in Europe. Pills are the most popular choice as women are increasingly preferring user dependent forms over the long acting reversible contraceptives. Moreover, availability of sexual health services and more number of individuals availing these services to obtain contraceptives and related information will drive the regional revenue share of contraceptives market.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/430

Asia Pacific contraceptives market will grow at significant rate owing to rising prevalence of STDs, increasing awareness campaigns to raise awareness about contraceptives and several government initiatives. Favourable family planning policy along with other reimbursement policies such as the AIDS care policy will positively impact business revenue.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://solutionrocket.com

This release was published on openPR.